Coho Partners’s Pfizer PFE Stock Holding History

Coho Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9,550	Closed	-$294K	–	59
2016 Q4	$294K	Hold	9,550	–	–	0.01%	46
2016 Q3	$307K	Hold	9,550	–	–	0.01%	49
2016 Q2	$319K	Hold	9,550	–	–	0.01%	47
2016 Q1	$269K	Sell	9,550 -4,194	-31%	-$120K	0.01%	49
2015 Q4	$421K	Hold	13,744	–	–	0.02%	46
2015 Q3	$410K	Hold	13,744	–	–	0.02%	48
2015 Q2	$437K	Sell	13,744 -746	-5%	-$24.3K	0.02%	40
2015 Q1	$478K	Buy	14,490 +527	+4%	+$16.8K	0.02%	38
2014 Q4	$413K	Buy	13,963 +219	+2%	+$6.28K	0.02%	39
2014 Q3	$386K	Hold	13,744	–	–	0.02%	37
2014 Q2	$387K	Hold	13,744	–	–	0.03%	37
2014 Q1	$419K	Hold	13,744	–	–	0.03%	36
2013 Q4	$399K	Hold	13,744	–	–	0.03%	38
2013 Q3	$375K	Buy	13,744 +531	+4%	+$14.4K	0.03%	39
2013 Q2	$351K	Buy	+13,213	New	+$365K	0.04%	41

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Coho Partners's PFE Position: Q1 2017 in Review

Coho Partners sold out of Pfizer (PFE) in Q1 2017, closing a stake of 9,550 shares — an estimated $294K sold.

Coho Partners first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $478K in Q1 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Coho Partners reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
Coho Partners sold 9,550 Pfizer shares in Q1 2017, an estimated $294K.
Coho Partners first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
Coho Partners's Pfizer position peaked at $478K in Q1 2015.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Coho Partners's 13F filing for Q1 2017, filed 12 May 2017.